Systematic (IUPAC) name | |
---|---|
1,2-dihydro- 1,5-dimethyl- 2-phenyl- 3H-pyrazol- 3-one | |
Clinical data | |
Pregnancy cat. | ? |
Legal status | ? |
Identifiers | |
CAS number | 60-80-0 |
ATC code | N02BB01 S02DA03 |
PubChem | CID 2206 |
DrugBank | DB01435 |
ChemSpider | 2121 |
UNII | T3CHA1B51H |
KEGG | D01776 |
ChEBI | CHEBI:31225 |
ChEMBL | CHEMBL277474 |
Synonyms | analgesine, antipyrine |
Chemical data | |
Formula | C11H12N2O |
Mol. mass | 188.226 g/mol |
SMILES | eMolecules & PubChem |
|
|
(verify) |
(what is this?)
Phenazone (INN), phenazon, antipyrine (USAN), or analgesine is an analgesic and antipyretic. It was first synthesized by Ludwig Knorr in 1883.[1] It is formed by reducing diortho- dinitrodiphenyl with sodium amalgam and methyl alcohol, or by heating diphenylene-ortho-dihydrazine with hydrochloric acid to 150 °C. It crystallizes in needles which melt at 156 °C. Potassium permanganate oxidizes it to pyridazine tetracarboxylic acid. Phenazone has an elimination half life of about 12 hours. [2]
Possible adverse effects include:
|